首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Disturbed lipoprotein composition in non-dialyzed, hemodialysis, continuous ambulatory peritoneal dialysis and post-transplant patients with chronic renal failure.
【24h】

Disturbed lipoprotein composition in non-dialyzed, hemodialysis, continuous ambulatory peritoneal dialysis and post-transplant patients with chronic renal failure.

机译:非透析,血液透析,连续非卧床腹膜透析和慢性肾功能衰竭患者移植后脂蛋白成分紊乱。

获取原文
获取原文并翻译 | 示例
           

摘要

Studies were carried out in 183 non-dialyzed, 123 hemodialysis, 81 continuous ambulatory peritoneal dialysis and 35 post-transplant patients and in 103 healthy subjects as a reference group. Lipids and apolipoprotein (apo)AI and apoB were determined using Roche kits. An anti-apoB antibody was used to separate apoB-containing apoCIII and apoE-triglyceride-rich lipoprotein (TRL) in the non-high-density lipoprotein (non-HDL) fraction from apoCIIInonB and apoEnonB in the HDL fraction in four groups of patients with chronic renal failure (CRF) and healthy subjects. Multivariate linear regression analysis was used to investigate the relationship between triglyceride (TG) or HDL-cholesterol (HDL-C) concentrations and lipoproteins. Dyslipidemia varied according to the degree of renal insufficiency, the type of dialysis and therapy regime in CRF patients. Lipoprotein disturbances were manifested by increased TG, non-HDL-C and TRL concentrations, and decreased HDL-C and apoAI concentrations, whereas post-renal transplant patients showed normalization of lipid and lipoprotein profiles, except for TG levels and total apoCIII and apoCIIInonB. The present study indicates that CRF patients have disturbed lipoprotein composition, and that hypertriglyceridemia and low HDL-C concentrations in these patients are multifactorial, being secondary to disturbed lipoproteins. The method using anti-apoB antibodies to separate apoB-containing lipoproteins in the non-HDL fraction from non-apoB-containing lipoproteins in HDL can be used in the diagnosis and treatment of patients with progression of renal failure or atherosclerosis. The variability of TG and HDL-C concentrations depends on the variability of TRL and cholesterol-rich lipoprotein concentrations, but the decreases in TG and increases in HDL-C concentrations are caused by apoAI concentration variability. These relationships, however, need to be confirmed in further studies.
机译:在183例非透析,123例血液透析,81例非卧床腹膜透析和35例移植后患者以及103例健康受试者中进行了研究。使用Roche试剂盒测定脂质和载脂蛋白(apo)AI和apoB。使用抗apoB抗体从四组患者的非高密度脂蛋白(non-HDL)组分中分离出apoCIIInonB和apoEnonB的非高密度脂蛋白(non-HDL)组分中的含apoB的apoCIII和富含apoE-甘油三酸酯的脂蛋白(TRL)慢性肾功能衰竭(CRF)和健康受试者。多元线性回归分析用于研究甘油三酸酯(TG)或HDL-胆固醇(HDL-C)浓度与脂蛋白之间的关系。血脂异常根据肾功能不全的程度,透析类型和治疗方案而异。脂蛋白紊乱表现为TG升高,非HDL-C和TRL浓度升高,HDL-C和apoAI浓度降低,而肾移植后患者除TG水平和总apoCIII和apoCIIInonB以外,均显示脂质和脂蛋白谱正常。本研究表明,CRF患者的脂蛋白成分受到干扰,而这些患者中的高甘油三酯血症和低HDL-C浓度是多因素的,继发于脂蛋白受损。使用抗apoB抗体将非HDL组分中的非HDL组分中的含apoB的脂蛋白与HDL中的非apoB的脂蛋白分离的方法可用于诊断和治疗肾衰竭或动脉粥样硬化进展的患者。 TG和HDL-C浓度的变异性取决于TRL和富含胆固醇的脂蛋白浓度的变异性,但是TG的降低和HDL-C浓度的升高是由apoAI浓度变异性引起的。但是,这些关系有待进一步研究证实。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号